A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma. - sprookjes - yvandenbroek - TriplyDB

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q35558293

about

The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.Anaplastic Thyroid Carcinoma, Version 2.2015.ALK: a tyrosine kinase target for cancer therapy.Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.Update on the cytologic features of papillary thyroid carcinoma variants.Anaplastic lymphoma kinase L1198F and G1201E mutations identified in anaplastic thyroid cancer patients are not ligand-independent.Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance.Molecular pathology and thyroid FNA.Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.Novel targeted therapies and immunotherapy for advanced thyroid cancers.Mechanisms of receptor tyrosine kinase activation in cancer.EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion Navigating Systemic Therapy in Advanced Thyroid Carcinoma: From Standard of Care to Personalized Therapy and Beyond

P2860

Q28076196-C75A6F55-0745-46A1-BAFC-BAD2DC882C25 Q36560914-F668C20E-8D78-41B7-B721-012C4D302D45 Q37179204-FC3F55E1-A8EF-4D38-B1E0-BFCF9C04A5BA Q37518624-DFE29BF7-16E2-4250-85E3-AC73DCB901CC Q38668044-3D7990DE-441E-4100-ADF6-E6718BBD050F Q39163041-17C38EB0-C212-414D-BC05-45753B3FFA82 Q42315727-B3439E82-9C0C-4A39-A6F5-9B3EECA7B001 Q47295202-F1ABC748-A5E1-4174-9DC8-E04E18255CC4 Q48254018-667C97A1-5C26-427E-8F77-879F87E4A6A8 Q48254756-8BCFABFB-9F99-4764-8390-98F27226FB41 Q49887965-E4EFC0AB-758A-4D05-BB89-E4C4D8788BF3 Q49888000-DE530B74-38C0-4CC1-A049-210CA7F5B76F Q50873415-C3E493AF-5B94-4C01-A29A-B00F140992F6 Q55026989-B8B3438B-8F6A-48C5-A17B-80F7362CCFA8 Q58701147-51ADC90B-A6A2-4DF6-B7B6-84B8A4904174 Q58784257-FC57D2CB-2B57-4F3B-A366-AA10094D880C

P2860

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q35558293

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@ast

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@en

type

label

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@ast

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@en

prefLabel

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@ast

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@en

P1433

Q35558293-F98FF067-6D28-48A6-9F4F-4C01BAC73762

P1476

Q35558293-E286947C-1A15-4005-8EED-043D35447541

P2093

Q35558293-0CC02EEC-E616-43B3-A1A0-AA55FB0F3AF5

Q35558293-117C4940-39BF-44C1-AE98-B9FC40E279DC

Q35558293-17BD6F5F-16DC-4798-8F21-8CD997EC8CD1

Q35558293-36A491CB-2BE5-4C6F-8280-FFD27B6F9FCA

Q35558293-8911F6A9-F3AF-4A1B-A6C0-B8445C6B2A40

Q35558293-8F607B5E-26F2-4BE4-97FD-8C1B8402C7CF

Q35558293-938BE00F-4C44-4BC1-8C84-B533D95BB364

Q35558293-9FC58195-A60E-4E9B-B142-D226DB34747D

Q35558293-AC0BF721-F329-4503-A719-3AB682065A1C

Q35558293-B5C5BD67-103A-4EEE-9B3A-D35952D1615B

P2860

Q35558293-03FFFAE0-2024-4B07-A388-257DA5263375

Q35558293-119854AC-D0F8-4C17-A1A7-955864098C6C

Q35558293-14128AB7-33FE-495A-8E26-78357688E017

Q35558293-2196C875-B93F-4B82-8CA1-87DB3AAD1546

Q35558293-2EB2F90E-CDC7-4239-9438-E53903E7ED77

Q35558293-33671593-187F-4914-9DFD-E2FB75C6323B

Q35558293-3DACEE6A-C05E-4527-9647-11578A02AB18

Q35558293-4865ED82-1B35-41F2-BC0B-B0C24B8AFB47

Q35558293-5B10A1DC-0F0A-4C08-8614-F7DAEEE4C166

Q35558293-5CB50A4B-8F60-4BB5-8080-D3AB6DB4C59E

P304

Q35558293-3AA71327-98FC-4586-B9ED-5888D8652C41

P31

Q35558293-D76DF43D-B130-4864-B00A-F386408295D3

P356

Q35558293-234AD030-FD04-4AFB-A6BC-3E64700C02B7

P407

Q35558293-D6332466-E020-4398-B80D-F90D48EBE0A1

P433

Q35558293-6063883B-E7CF-41C9-B4E6-1BF4D90188AE

P478

Q35558293-02D7CE62-05FF-4BFC-8B00-9D30311A2D05

P50

Q35558293-CBCBD58F-9D13-45DA-921F-858D1067BB07

Q35558293-E8685E81-C737-44C4-B060-C8665D52402A

P577

Q35558293-9DB51E45-B7CA-4BE0-9543-09C84B447448

P698

Q35558293-95DAF1A8-248A-4D40-AFEC-38A49D705721

P932

Q35558293-BBAAAA71-12E7-4C3A-998A-739707D38458

P356

PAS.0000000000000368

P1433

The American Journal of Surgical Pathology

P1476

A detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.

@en

P2093

Adele Clarkson

http://www.w3.org/2001/XMLSchema#string

Ahmad Aniss

http://www.w3.org/2001/XMLSchema#string

Angela Chou

http://www.w3.org/2001/XMLSchema#string

Anthony J Gill

http://www.w3.org/2001/XMLSchema#string

Bruce G Robinson

http://www.w3.org/2001/XMLSchema#string

Carmen Cussigh

http://www.w3.org/2001/XMLSchema#string

Christina I Selinger

http://www.w3.org/2001/XMLSchema#string

Christopher W Toon

http://www.w3.org/2001/XMLSchema#string

Diana L Learoyd

http://www.w3.org/2001/XMLSchema#string

Leigh W Delbridge

http://www.w3.org/2001/XMLSchema#string

P2860

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Integrated genomic characterization of papillary thyroid carcinoma

Identification of a recurrent STRN/ALK fusion in thyroid carcinomas

Mechanisms of chromosomal rearrangements in solid tumors: the model of papillary thyroid carcinoma.

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Molecular pathogenesis and mechanisms of thyroid cancer

Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.

Rearrangements of NTRK1 gene in papillary thyroid carcinoma.

P304

652-659

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0000000000000368

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Roderick J Clifton-Bligh

Christine J O'Neill

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25501013

http://www.w3.org/2001/XMLSchema#string

P932

4415964

http://www.w3.org/2001/XMLSchema#string